• Alkermes launches the first-ever injectable drug to treat alcoholism - The Boston Globe
  The first-ever injectable drug to help alcoholics stay sober officially hit the market yesterday: Vivitrol , a once-a-month shot made by Cambridge biotechnology company Alkermes Inc.
  By docalex in Substance abuse, Abstinence, Harm Reduction with alcohol-use-disorder alcoholism naltrexone pharmacotherapy substance-abuse vivitrol
• Whatever Happened to Controlled Drinking
  In the '60s and '70s, the topic of controlled drinking as an intervention goal was a flashpoint for controversy. Three decades later, moderate problem-free drinking is widely reported as a treatment outcome, and has become a mainstream early intervention goal. -- Even when the announced treatment goal is abstention, about 10% of treated cases are found to be drinking moderately at follow-up. Empirical guidelines are presented for estimating the probability of a client succeeding with moderation versus abstinence, based on scores from the Alcohol Dependence Scale and the MAST.
  By docalex in Substance abuse, Abstinence, Harm Reduction with alcohol-use-disorder alcoholism controlled-drinking harm-reduction substance-abuse by 2 users
• Long-Term Antabuse Treatment More Effective
  A nine-year study of chronic alcoholics in Europe, where alcohol-deterrent drugs such as disulfiram (Antabuse) and calcium carbimide (Temposil) are more widely used than in the United States, shows that the psychological effects of long-term treatment can produce abstinence rates...
  By docalex in Substance abuse, Abstinence, Harm Reduction with abstinence alcohol-use-disorder alcoholism disulfiram pharmacotherapy

Results 1 - 3 for alcohol-use-disorder